GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Total Long-Term Assets

Ananda Pharma (STU:1FX) Total Long-Term Assets : €3.73 Mil (As of Jul. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Ananda Pharma's Total Long-Term Assets for the quarter that ended in Jul. 2024 was €3.73 Mil.

Ananda Pharma Total Long-Term Assets Historical Data

The historical data trend for Ananda Pharma's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Total Long-Term Assets Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Total Long-Term Assets
0.52 1.52 1.43 2.70 7.08

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jul24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.70 3.74 7.08 8.73 3.73

Ananda Pharma Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Ananda Pharma Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Total Long-Term Assets
Comparable Companies
LSE:PXS LSE:STX LSE:CEL LSE:N4P LSE:EAH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR
Traded in Other Exchanges
ANA:UK
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.anandapharma.co.uk
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines